Skip to content
★ Sign in to follow
JL
Total declarations
47
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (20 ops.)
€560k

Latest filing published 07 Mar 2013 for AtriCure, Inc., €68k.

Insider track record

Disclosed buys
0
Disclosed sells
20
Signal history

No signal scores available.

James L. Lucky: trading record in brief

James L. Lucky appears in our data through filings on AtriCure, Inc. shares, published by SEC (Form 4). We count 47 filings; the first trade dates from 15 February 2008 and the latest from 6 March 2013.

No open-market purchase appears, only 20 sales worth €560k. Other entries cover 22 share grants and 5 option exercises. Since January 2013: no purchases and 4 sales on the market.

On 7 March 2013 came the latest disclosure, an option exercise for €68k in AtriCure, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to James L. Lucky

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations47 total
  • ◇
    VP, Clinical, Regulatory & QSExecutivesAtriCure, Inc.
    88,437 USD0SEC
    13,949 shares@ US$6.34Common StockSEC:0001181431-13-015244:0
  • ▼
    VP, Clinical, Regulatory & QSExecutivesAtriCure, Inc.
    113,405 USD0SEC
    13,949 shares@ US$8.13Common StockSEC:0001181431-13-015244:1
  • ◇
    VP, Clinical, Regulatory & QSExecutivesAtriCure, Inc.
    176,400 USD0SEC
    31,500 shares@ US$5.60Common StockSEC:0001181431-13-015244:2
  • ▼
    VP, Clinical, Regulatory & QSExecutivesAtriCure, Inc.
    256,095 USD0SEC
    31,500 shares@ US$8.13Common StockSEC:0001181431-13-015244:3
  • ◇
    VP, Clinical, Regulatory & QSExecutivesAtriCure, Inc.
    14,399 USD0SEC
    9,473 shares@ US$1.52Common StockSEC:0001181431-13-015244:4
  • ▼
    VP, Clinical, Regulatory & QSExecutivesAtriCure, Inc.
    5,064 USD0SEC
    616 shares@ US$8.22Common StockSEC:0001181431-13-015244:5
  • ▼
    VP, Clinical, Regulatory & QSExecutivesAtriCure, Inc.
    32,880 USD0SEC
    4,000 shares@ US$8.22Common StockSEC:0001181431-13-015244:6
  • ◆
    VP, Clinical, Regulatory & QSExecutivesAtriCure, Inc.
    7,225 USD0SEC
    851 shares@ US$8.49Common StockSEC:0001181431-13-011214:0
  • ◆
    VP, Clinical, Regulatory & QSExecutivesAtriCure, Inc.
    9,440 USD0SEC
    1,136 shares@ US$8.31Common StockSEC:0001181431-13-010340:0
  • ◆
    VP, Clinical, Regulatory & QSExecutivesAtriCure, Inc.
    6,814 USD0SEC
    835 shares@ US$8.16Common StockSEC:0001181431-13-009005:0
  • ◆
    VP, Regulatory Affairs and QSExecutivesAtriCure, Inc.
    0SEC
    2,500 shares0Common StockSEC:0001181431-13-001583:0
  • ◆
    VP, Regulatory Affairs and QSExecutivesAtriCure, Inc.
    2,101 USD0SEC
    358 shares@ US$5.87Common StockSEC:0001181431-13-000136:0
  • ◆
    VP, Regulatory Affairs and QSExecutivesAtriCure, Inc.
    18,259 USD0SEC
    2,166 shares@ US$8.43Common StockSEC:0001181431-12-042811:0
  • ◆
    VP, Regulatory Affairs and QSExecutivesAtriCure, Inc.
    2,108 USD0SEC
    258 shares@ US$8.17Common StockSEC:0001181431-12-039117:0
  • ▼
    VP, Regulatory Affairs and QSExecutivesAtriCure, Inc.
    4,236 USD0SEC
    463 shares@ US$9.15Common StockSEC:0001181431-12-028661:0
  • ▼
    VP, Regulatory Affairs and QSExecutivesAtriCure, Inc.
    68,210 USD0SEC
    7,537 shares@ US$9.05Common StockSEC:0001181431-12-028661:1
  • ▼
    VP, Regulatory Affairs and QSExecutivesAtriCure, Inc.
    57,750 USD0SEC
    5,500 shares@ US$10.50Common StockSEC:0001181431-12-013739:0
  • ◆
    VP, Regulatory Affairs and QAExecutivesAtriCure, Inc.
    9,811 USD0SEC
    986 shares@ US$9.95Common StockSEC:0001181431-12-010284:0
  • ◆
    VP, Regulatory Affairs and QAExecutivesAtriCure, Inc.
    0SEC
    12,500 shares0Common StockSEC:0001181431-12-009402:0
  • ◆
    VP, Regulatory Affairs and QAExecutivesAtriCure, Inc.
    8,730 USD0SEC
    790 shares@ US$11.05Common StockSEC:0001181431-12-007727:0
  • ◆
    VP, Regulatory Affairs and QAExecutivesAtriCure, Inc.
    2,096 USD0SEC
    222 shares@ US$9.44Common StockSEC:0001181431-12-000203:0
  • ◆
    VP, Regulatory Affairs and QAExecutivesAtriCure, Inc.
    27,358 USD0SEC
    2,248 shares@ US$12.17Common StockSEC:0001181431-11-043177:0
  • ◆
    VP, Regulatory Affairs and QAExecutivesAtriCure, Inc.
    2,099 USD0SEC
    241 shares@ US$8.71Common StockSEC:0001181431-11-039614:0
  • ▼
    VP, Regulatory Affairs and QAExecutivesAtriCure, Inc.
    40,500 USD0SEC
    3,000 shares@ US$13.50Common StockSEC:0001181431-11-037002:0
  • ▼
    VP, Regulatory Affairs and QAExecutivesAtriCure, Inc.
    87,386 USD0SEC
    6,536 shares@ US$13.37Common StockSEC:0001181431-11-036561:0

25 of 47 declarations